Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.67
+0.61982.29%
Volume:29.32M
Turnover:805.93M
Market Cap:157.32B
PE:20.35
High:27.68
Open:27.25
Low:27.09
Close:27.05
52wk High:27.69
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:0.49
T/O Rate:0.52%
Dividend:1.72
Dividend Rate:6.22%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.58%
ROA:5.19%
PB:1.70
PE(LYR):20.28

Loading ...

Pfizer Inc. Publishes Transcript of Q4 2025 Earnings Call Event

Reuters
·
1 hour ago

Pfizer Dec-Quarter Net Profit 1.42 Billion Rupees

Reuters
·
Feb 09

DIARY-India economic, corporate events on February 9

Reuters
·
Feb 09

TrumpRx Is Here. Most People Won't Benefit. -- Barrons.com

Dow Jones
·
Feb 07

Pfizer Halts Early-Stage Trial for PF-07258669 in Older Adults: What Investors Should Know

TIPRANKS
·
Feb 07

Pfizer Completes Mid-Stage Trial of New Obesity Drug Candidate PF-07976016

TIPRANKS
·
Feb 07

Pfizer says FDA grants Priority Review for sBLA for Hympavzi

TIPRANKS
·
Feb 06

FDA prüft Zulassung von HYMPAVZI für Patienten mit Hämophilie und Inhibitoren

Reuters
·
Feb 06

FDA Grants Priority Review for Hympavzi® (Marstacimab) Sbla for the Treatment of Two Hemophilia a or B Patient Populations With Significant Medical Need

THOMSON REUTERS
·
Feb 06

Pfizer - FDA Sets Pdufa Action Date for Hympavzi in Q2 2026

THOMSON REUTERS
·
Feb 06

White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications -- WSJ

Dow Jones
·
Feb 06

BRIEF-Pfizer Launches Cost Savings Program On TrumpRx Lowering Drug Costs For Millions Of Americans

Reuters
·
Feb 06

Pfizer: Program Offers Savings on Over 30 Brands Spanning Women's Health, Migraine, Arthritis, Rare Disease and More

THOMSON REUTERS
·
Feb 06

Pfizer Launches Cost Savings Program on Trumprx Lowering Drug Costs for Millions of Americans

THOMSON REUTERS
·
Feb 06

Pfizer Inc. (PFE US) - Obesity Pipeline De-Risking Drives Re-Rating Potential

Smartkarma
·
Feb 06

Pfizer Stock Forecast: Trending Analysts See Cautious Upside

TIPRANKS
·
Feb 05

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 05

Pfizer and BioNTech Pause modRNA Shingles Ambitions

TIPRANKS
·
Feb 05

Pfizer Price Target Maintained With a $27.00/Share by Cantor Fitzgerald

Dow Jones
·
Feb 05

BMO Capital Reaffirms Their Buy Rating on Pfizer (PFE)

TIPRANKS
·
Feb 04